| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1645 | (+)-PHNO hydrochloride |
1645.0001: 1 mg per vial 1645.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Reference standard for [11C]-(+)-PHNO
|
||
| Molar Mass: 283.79 | ||
| C15H21NO2 ⋅ HCl | ||
| [99705-65-4] | ||
| Off-white solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index names: 2H-Naphtho[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride (1:1), (4aR,10bR)-; (4aR,10bR)- 2H-Naphth[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)- |
||
|
Synonymes: Noxazinal hydrochloride, Naxagolide hydrochloride, Nazagolide hydrochloride, Dopazinol hydrochloride, L647339, MK 458, (+)-PHNO hydrochloride, (+)-4-propyl-9-hydroxynaphthoxazine hydrochloride; [11C]-(+)-PHNO = [11C]-(+)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol |
||
|
Literature: 1. Wilson et al. [11C]-(+)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a Potential Radiotracer for in Vivo Imaging of the Dopamine D2 High-Affinity State with Positron Emission Tomography. J. Med. Chem. 2005, 48, 4153-4160. |
||
| 2. Boileau et al. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease. Brain, 2009, 132, 1366-1375. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1